FSM Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.49M Buy
2,078
+192
+10% +$196K 0.27% 53
2026
Q1
$1.73M Buy
1,886
+19
+1% +$19.3K 0.22% 58
2025
Q4
$2.01M Buy
1,867
+75
+4% +$71.7K 0.27% 52
2025
Q3
$1.37M Buy
1,792
+181
+11% +$135K 0.19% 70
2025
Q2
$1.24M Buy
1,611
+127
+9% +$98.7K 0.2% 72
2025
Q1
$1.23M Buy
1,484
+188
+15% +$156K 0.28% 51
2024
Q4
$982K Sell
1,296
-110
-8% -$91.1K 0.24% 60
2024
Q3
$1.25M Buy
1,406
+161
+13% +$145K 0.33% 49
2024
Q2
$1.13M Hold
1,245
0.38% 47
2024
Q1
$968K Sell
1,245
-95
-7% -$67.6K 0.34% 51
2023
Q4
$781K Buy
1,340
+16
+1% +$9.34K 0.33% 56
2023
Q3
$711K Buy
1,324
+116
+10% +$59.8K 0.36% 55
2023
Q2
$531K Buy
1,208
+244
+25% +$102K 0.27% 77
2023
Q1
$331K Buy
964
+2
+0.2% +$675 0.19% 103
2022
Q4
$352K Sell
962
-78
-8% -$27.7K 0.25% 90
2022
Q3
$336K Sell
1,040
-17
-2% -$5.39K 0.28% 89
2022
Q2
$320K Buy
+1,057
New +$317K 0.32% 78

Other funds holding LLY

FSM Wealth Advisors's LLY Position: Q2 2026 in Review

FSM Wealth Advisors increased its Eli Lilly (LLY) stake by 10% in Q2 2026, buying an estimated $196K and bringing the position to 2,078 shares worth $2.49M. The position accounts for 0.27% of the portfolio, ranked #53.

FSM Wealth Advisors first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 2,206 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • FSM Wealth Advisors held 2,078 shares of Eli Lilly worth $2.49M as of Q2 2026.
  • FSM Wealth Advisors bought 192 Eli Lilly shares in Q2 2026, an estimated $196K.
  • Eli Lilly made up 0.27% of FSM Wealth Advisors's portfolio in Q2 2026, its #53 holding.
  • FSM Wealth Advisors first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 2,206 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on FSM Wealth Advisors's 13F filing for Q2 2026, filed 15 Jul 2026.